New Strategies for Blood Donor Screening for Hepatitis B Virus

@article{Kuhns2006NewSF,
  title={New Strategies for Blood Donor Screening for Hepatitis B Virus},
  author={Dr Mary C. Kuhns and Michael P. Busch},
  journal={Molecular Diagnosis & Therapy},
  year={2006},
  volume={10},
  pages={77-91}
}
Serologic testing for hepatitis B virus (HBV) surface antigen (HBsAg) and antibody to HBV core antigen (anti-HBc) has historically been the foundation of blood screening, while HBV nucleic acid testing (NAT) was recently developed to detect HBsAg-negative, anti-HBc-negative blood units donated during early acute infection. Comparison data on seroconversion panels using HBsAg assays of varying sensitivities and pooled- or single-sample NAT, along with viral load estimates corresponding to HBsAg… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 51 CITATIONS, ESTIMATED 57% COVERAGE

Hepatitis B virus Genotypes in West Azarbayjan Province, Northwest Iran

  • Open access Macedonian journal of medical sciences
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing.

  • Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
  • 2017

FILTER CITATIONS BY YEAR

2007
2019

CITATION STATISTICS

  • 1 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

  • Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
  • 2004
VIEW 11 EXCERPTS

Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003.

  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2005
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Residual risk

M Alvarez do Barrio, RG Diez, JMH Sanchez
  • Eurosurveillance
  • 2005
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

A new strategy for estimating risks of Acknowledgments transfusiontransmitted viral infections based on rates of detection of recently infected donors

SA Glynn
  • Transfusion
  • 2005

Blood safety and nucleic acid testing in Europe.

  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2005

Evaluation of a new PCR assay withblood donors ?

MP Busch, C Drosten, M Weber, E Seifried
  • Transfusion
  • 2005

Health and economic impact of posttransfusion hepatitis B and costsystem

KR Loeb, KR Jerome, J Goddard, A Pereira
  • Hepatology
  • 2005